Supporting prostate cancer research

Current Research Projects

Our research covers the physical, psychosocial, and financial issues of cancer, beyond the diagnosis and treatment phases and includes issues related to the ability to get health care and follow-up treatment, late effects of treatment, second cancers, and quality of life. Family members, friends, and caregivers are also included in our research.

The Who and When of prostate cancer online communities

This study explores who does and who does not use online prostate cancer communities. It seeks to identify what influences your use of online prostate cancer communities, and what deters you from using online prostate cancer communities.


Optimising the Cancer Nutrition Path: invitation to participate in Patient and Carer Survey

As a consumer of cancer care in Victoria, patient or carer, I would like to invite you to participate in a survey. The survey aims to inform the development of a cancer nutrition care pathway. We are hoping to receive as many responses as possible in order to learn about your nutrition needs and experiences during your cancer journey.


Navigate: Randomised Control Trial of an online treatment decision aid for men with low-risk prostate cancer and their partners.

Men recently diagnosed with low risk prostate cancer are needed to take part in a study assessing a new online tool designed to help navigate their treatment. The Navigate clinical trial is recruiting men diagnosed with low-risk or localised prostate cancer within the last three months.


Prostate Cancer Health and Fitness Online: The development and pilot testing of an internet physical activity program for prostate cancer survivors.

Research has shown that participating in physical activity is beneficial for prostate cancer survivors. Some men have expressed interest to use the internet as a way to find information on their own. This study asks whether an internet program could be a good way for men to receive information about physical activity.


TheraP: A randomised phase 2 trial of 177Lu-PSMA617 theranostic versus cabazitaxel in progressive metastatic castration resistant prostate cancer.

Lutetium-177 PSMA radionuclide therapy (Lu-PSMA) is a new treatment for advanced prostate cancer. Lu-PSMA is a radioactive molecule that specifically attaches to cells with high amounts of PSMA on the surface of the cells.


Weight loss programme for prostate cancer patients.

Androgen deprivation therapy (ADT) is a common treatment for prostate cancer. One of the many possible side effects of this treatment is weight gain. Lifestyle changes utilising exercise and diet have been demonstrated as safe and result in improved health, physical function, and quality of life for cancer patients. The purpose of this study is to assess the efficacy of an exercise and diet programme designed to induce weight loss.


Advanced Prostate Cancer Patient Value Mapping Study

Community and Patient Preference Research (CaPPRe) is working with Prostate Cancer Foundation of Australia to conduct research with men who have metastatic prostate cancer.


EXERCISE THERAPY: Counteracting mental health issues in men with prostate cancer through exercise.

The objective of this study is to test the effect of a targeted exercise program for prostate cancer patients. The aim of the program is to help manage distress in these men.


FIRE: A pilot study evaluating focal irreversible electroporation as treatment for participants with recurrent prostate cancer after radiotherapy.

The purpose of the study is to investigate the IRE (focal irreversible electroporation) procedure in a set of patients whose cancer has returned after initial radiation therapy. It will look at the safety profile, quality of life and cancer outcomes after the procedure.


ProsD: Nutritional supplements for men with prostate cancer

The ProsD clinical trial is currently recruiting men with prostate cancer who are on Active Surveillance from NSW, Victoria and Queensland. The aim of this phase II trial is to test the benefits of a nutritional supplement in preventing prostate cancer progression. Men who join this trial will be asked to take a nutritional supplement every month whilst on active surveillance.


Join us today!

Pathfinder is a unique prostate cancer research register that enables prostate cancer survivors to participate in research for a brighter future with their loved ones.

It will enable researchers to save valuable time and money recruiting participants for their projects, so that they can spend more time delivering health benefits to those in need. Click the button to the right to register!